{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:48:49Z","timestamp":1776674929252,"version":"3.51.2"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272648"],"award-info":[{"award-number":["82272648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82202886"],"award-info":[{"award-number":["82202886"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Plan Project of Suzhou","award":["SKY2022133"],"award-info":[{"award-number":["SKY2022133"]}]},{"name":"the Science and Technology Plan Project of Suzhou","award":["SKY2023160"],"award-info":[{"award-number":["SKY2023160"]}]},{"DOI":"10.13039\/100022944","name":"Suzhou Gusu Medical Youth Talent","doi-asserted-by":"publisher","award":["GSWS2021001"],"award-info":[{"award-number":["GSWS2021001"]}],"id":[{"id":"10.13039\/100022944","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Medical Key Discipline","award":["ZDXK202201"],"award-info":[{"award-number":["ZDXK202201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07975-9","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:47:32Z","timestamp":1773240452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SHMT2 inhibition triggers mitochondrial apoptosis to suppress lung adenocarcinoma progression"],"prefix":"10.1186","volume":"24","author":[{"given":"Yili","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-an","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"5","key":"7975_CR1","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1515\/cclm-2022-1108","volume":"61","author":"B Melichar","year":"2023","unstructured":"Melichar B. Biomarkers in the management of lung cancer: changing the practice of thoracic oncology. Clin Chem Lab Med. 2023;61(5):906\u201320.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"7975_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00408-025-00801-x","volume":"203","author":"H Jeon","year":"2025","unstructured":"Jeon H, Wang S, Song J, Gill H, Cheng H. Update 2025: Management of Non\u2013Small-Cell Lung Cancer. Lung. 2025;203(1):53.","journal-title":"Lung"},{"issue":"1","key":"7975_CR3","first-page":"56","volume":"75","author":"LG Collins","year":"2007","unstructured":"Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. Am Fam Physician. 2007;75(1):56\u201363.","journal-title":"Am Fam Physician"},{"issue":"4","key":"7975_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10142-023-01245-3","volume":"23","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Xiong J, Gao Y, Yi R, Xu Y, Chen Q, et al. Mitochondria-related lncRNAs: predicting prognosis, tumor microenvironment and treatment response in lung adenocarcinoma. Funct Integr Genom. 2023;23(4):323.","journal-title":"Funct Integr Genom"},{"issue":"3","key":"7975_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","volume":"5","author":"C Zappa","year":"2016","unstructured":"Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5(3):288\u2013300.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"7975_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13046-021-02200-5","volume":"41","author":"L Ma","year":"2022","unstructured":"Ma L, Xue X, Zhang X, Yu K, Xu X, Tian X, et al. The essential roles of m(6)A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma. J experimental Clin cancer research: CR. 2022;41(1):36.","journal-title":"J experimental Clin cancer research: CR"},{"key":"7975_CR7","doi-asserted-by":"publisher","first-page":"115891","DOI":"10.1016\/j.biopha.2023.115891","volume":"169","author":"Y Li","year":"2023","unstructured":"Li Y, Yan B, He S. Advances and challenges in the treatment of lung cancer. Biomed Pharmacother. 2023;169:115891.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"7975_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39\u201351.","journal-title":"J Thorac Oncol"},{"key":"7975_CR9","doi-asserted-by":"crossref","unstructured":"\u0106eriman Krsti\u0107 V, Soldatovi\u0107 I, Gaji\u0107 M, Samard\u017ei\u0107 N, Stevi\u0107 R, \u010coli\u0107 N, et al. Long-term outcomes in patients with locally advanced and metastatic non-small cell lung cancer with high PD-L1 expression. Current Oncology (Toronto, Ont). 2025;32(4).","DOI":"10.3390\/curroncol32040229"},{"issue":"1","key":"7975_CR10","doi-asserted-by":"publisher","first-page":"e35476","DOI":"10.1002\/cncr.35476","volume":"131","author":"Y Wang","year":"2025","unstructured":"Wang Y, Kondrat K, Adhikari J, Nguyen Q, Yu Q, Uprety D. Survival trends among patients with metastatic non-small cell lung cancer before and after the approval of immunotherapy in the United States: A Surveillance, Epidemiology, and End Results database-based study. Cancer. 2025;131(1):e35476.","journal-title":"Cancer"},{"issue":"1","key":"7975_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molmed.2019.06.009","volume":"26","author":"KG Roth","year":"2020","unstructured":"Roth KG, Mambetsariev I, Kulkarni P, Salgia R. The Mitochondrion as an Emerging Therapeutic Target in Cancer. Trends Mol Med. 2020;26(1):119\u201334.","journal-title":"Trends Mol Med"},{"key":"7975_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.redox.2017.09.003","volume":"14","author":"SJ Han","year":"2018","unstructured":"Han SJ, Choi HS, Kim JI, Park JW, Park KM. IDH2 deficiency increases the liver susceptibility to ischemia-reperfusion injury via increased mitochondrial oxidative injury. Redox Biol. 2018;14:142\u201353.","journal-title":"Redox Biol"},{"issue":"9","key":"7975_CR13","doi-asserted-by":"publisher","first-page":"e18353","DOI":"10.1111\/jcmm.18353","volume":"28","author":"R Ding","year":"2024","unstructured":"Ding R, Wang Y, Xu L, Sang S, Wu G, Yang W, et al. QiDongNing induces lung cancer cell apoptosis via triggering P53\/DRP1-mediated mitochondrial fission. J Cell Mol Med. 2024;28(9):e18353.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"7975_CR14","doi-asserted-by":"publisher","first-page":"G100","DOI":"10.1152\/ajpgi.00329.2014","volume":"309","author":"M Cahova","year":"2015","unstructured":"Cahova M, Palenickova E, Dankova H, Sticova E, Burian M, Drahota Z, et al. Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation. Am J Physiol Gastrointest liver Physiol. 2015;309(2):G100\u201311.","journal-title":"Am J Physiol Gastrointest liver Physiol"},{"issue":"5","key":"7975_CR15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.neuint.2012.11.009","volume":"62","author":"S Manzanero","year":"2013","unstructured":"Manzanero S, Santro T, Arumugam TV. Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem Int. 2013;62(5):712\u20138.","journal-title":"Neurochem Int"},{"issue":"8","key":"7975_CR16","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s12276-023-01046-5","volume":"55","author":"TT Nguyen","year":"2023","unstructured":"Nguyen TT, Wei S, Nguyen TH, Jo Y, Zhang Y, Park W, et al. Mitochondria-associated programmed cell death as a therapeutic target for age-related disease. Exp Mol Med. 2023;55(8):1595\u2013619.","journal-title":"Exp Mol Med"},{"issue":"7","key":"7975_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.tim.2021.12.011","volume":"30","author":"J Foo","year":"2022","unstructured":"Foo J, Bellot G, Pervaiz S, Alonso S. Mitochondria-mediated oxidative stress during viral infection. Trends Microbiol. 2022;30(7):679\u201392.","journal-title":"Trends Microbiol"},{"issue":"3","key":"7975_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan K, Werner M, Chandel NS. Mitochondrial Metabolism as a Target for Cancer Therapy. Cell Metabol. 2020;32(3):341\u201352.","journal-title":"Cell Metabol"},{"issue":"1","key":"7975_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13046-023-02927-3","volume":"42","author":"HJ Yun","year":"2023","unstructured":"Yun HJ, Li M, Guo D, Jeon SM, Park SH, Lim JS, et al. AMPK-HIF-1\u03b1 signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth. J experimental Clin cancer research: CR. 2023;42(1):340.","journal-title":"J experimental Clin cancer research: CR"},{"issue":"10","key":"7975_CR20","doi-asserted-by":"publisher","first-page":"165841","DOI":"10.1016\/j.bbadis.2020.165841","volume":"1866","author":"AM Li","year":"2020","unstructured":"Li AM, Ye J. Reprogramming of serine, glycine and one-carbon metabolism in cancer. Biochim et Biophys acta Mol basis disease. 2020;1866(10):165841.","journal-title":"Biochim et Biophys acta Mol basis disease"},{"issue":"19","key":"7975_CR21","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.7150\/jca.60170","volume":"12","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Zhang J, Xu M, Chen F, Zi R, Yue J, et al. Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis. J Cancer. 2021;12(19):5888\u201394.","journal-title":"J Cancer"},{"key":"7975_CR22","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1038\/ncomms4128","volume":"5","author":"R Nilsson","year":"2014","unstructured":"Nilsson R, Jain M, Madhusudhan N, Sheppard NG, Strittmatter L, Kampf C, et al. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun. 2014;5:3128.","journal-title":"Nat Commun"},{"issue":"12","key":"7975_CR23","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1158\/2159-8290.CD-14-0250","volume":"4","author":"J Ye","year":"2014","unstructured":"Ye J, Fan J, Venneti S, Wan YW, Pawel BR, Zhang J, et al. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov. 2014;4(12):1406\u201317.","journal-title":"Cancer Discov"},{"issue":"10","key":"7975_CR24","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/s41417-022-00470-5","volume":"29","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Liu Z, Wang X, Jian H, Xiao H, Wen T. SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells. Cancer Gene Ther. 2022;29(10):1514\u201327.","journal-title":"Cancer Gene Ther"},{"issue":"7690","key":"7975_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nature25460","volume":"554","author":"RJ Morscher","year":"2018","unstructured":"Morscher RJ, Ducker GS, Li SH, Mayer JA, Gitai Z, Sperl W, et al. Mitochondrial translation requires folate-dependent tRNA methylation. Nature. 2018;554(7690):128\u201332.","journal-title":"Nature"},{"issue":"7","key":"7975_CR26","doi-asserted-by":"publisher","first-page":"111233","DOI":"10.1016\/j.celrep.2022.111233","volume":"40","author":"E Pranzini","year":"2022","unstructured":"Pranzini E, Pardella E, Muccillo L, Leo A, Nesi I, Santi A, et al. SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis. Cell Rep. 2022;40(7):111233.","journal-title":"Cell Rep"},{"issue":"7","key":"7975_CR27","first-page":"3405","volume":"12","author":"SY Xie","year":"2022","unstructured":"Xie SY, Shi DB, Ouyang Y, Lin F, Chen XY, Jiang TC, et al. SHMT2 promotes tumor growth through VEGF and MAPK signaling pathway in breast cancer. Am J cancer Res. 2022;12(7):3405\u201321.","journal-title":"Am J cancer Res"},{"key":"7975_CR28","doi-asserted-by":"crossref","unstructured":"Wang W, Wang M, Du T, Hou Z, You S, Zhang S, et al. SHMT2 promotes gastric cancer development through regulation of HIF1\u03b1\/VEGF\/STAT3 signaling. Int J Mol Sci. 2023;24(8).","DOI":"10.3390\/ijms24087150"},{"issue":"7","key":"7975_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","volume":"16","author":"X Li","year":"2019","unstructured":"Li X, Wenes M, Romero P, Huang SC, Fendt SM, Ho PC. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat Rev Clin Oncol. 2019;16(7):425\u201341.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"7975_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2478\/enr-2024-0016","volume":"58","author":"OH Minchenko","year":"2024","unstructured":"Minchenko OH, Sliusar MY, Khita OO, Viletska YM, Luzina OY, Danilovskyi SV, et al. Endoplasmic reticulum stress-dependent regulation of the expression of serine hydroxymethyltransferase 2 in glioblastoma cells. Endocr Regul. 2024;58(1):144\u201352.","journal-title":"Endocr Regul"},{"key":"7975_CR31","first-page":"3758697","volume":"2022","author":"X Cui","year":"2022","unstructured":"Cui X, Cui Y, Du T, Jiang X, Song C, Zhang S, et al. SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression. Can J Gastroenterol Hepatol. 2022;2022:3758697.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"16","key":"7975_CR32","doi-asserted-by":"publisher","first-page":"11294","DOI":"10.1021\/acs.jmedchem.3c00763","volume":"66","author":"MJ Nayeen","year":"2023","unstructured":"Nayeen MJ, Katinas JM, Magdum T, Shah K, Wong JE, O\u2019Connor CE, et al. Structure-Based Design of Transport-Specific Multitargeted One-Carbon Metabolism Inhibitors in Cytosol and Mitochondria. J Med Chem. 2023;66(16):11294\u2013323.","journal-title":"J Med Chem"},{"issue":"2","key":"7975_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/cbdd.13774","volume":"97","author":"Y Han","year":"2021","unstructured":"Han Y, He L, Qi Y, Zhao Y, Pan Y, Fang B, et al. Identification of three new compounds that directly target human serine hydroxymethyltransferase 2. Chem Biol Drug Des. 2021;97(2):221\u201330.","journal-title":"Chem Biol Drug Des"},{"key":"7975_CR34","doi-asserted-by":"publisher","first-page":"6104753","DOI":"10.1155\/genr\/6104753","volume":"2025","author":"Q Guo","year":"2025","unstructured":"Guo Q, Huang GH, Chen P, Guo C. Upregulated Expression of SHMT2 Predicts Poor Survival of Lung Adenocarcinoma. Genet Res. 2025;2025:6104753.","journal-title":"Genet Res"},{"issue":"18","key":"7975_CR35","first-page":"e2307834","volume":"11","author":"T Han","year":"2024","unstructured":"Han T, Wang Y, Cheng M, Hu Q, Wan X, Huang M, et al. Phosphorylated SHMT2 Regulates Oncogenesis Through m(6)A Modification in Lung Adenocarcinoma. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2024;11(18):e2307834.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"7975_CR36","first-page":"6647122","volume":"2021","author":"L Luo","year":"2021","unstructured":"Luo L, Zheng Y, Lin Z, Li X, Li X, Li M, et al. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma. J Immunol Res. 2021;2021:6647122.","journal-title":"J Immunol Res"},{"issue":"43","key":"7975_CR37","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1073\/pnas.1706617114","volume":"114","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Ghergurovich JM, Mainolfi N, Suri V, Jeong SK, Hsin-Jung Li S, et al. Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA. 2017;114(43):11404\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"7975_CR38","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1182\/blood.2021012081","volume":"139","author":"AC Wilke","year":"2022","unstructured":"Wilke AC, Doebele C, Zindel A, Lee KS, Rieke SA, Ceribelli M, et al. SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Blood. 2022;139(4):538\u201353.","journal-title":"Blood"},{"issue":"6","key":"7975_CR39","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.7150\/thno.48699","volume":"11","author":"C Liu","year":"2021","unstructured":"Liu C, Wang L, Liu X, Tan Y, Tao L, Xiao Y, et al. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting \u03b2-catenin degradation. Theranostics. 2021;11(6):2966\u201386.","journal-title":"Theranostics"},{"issue":"10","key":"7975_CR40","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1158\/1535-7163.MCT-19-0037","volume":"18","author":"AS Dekhne","year":"2019","unstructured":"Dekhne AS, Shah K, Ducker GS, Katinas JM, Wong-Roushar J, Nayeen MJ, et al. Novel Pyrrolo[3,2-d]pyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor Efficacy. Mol Cancer Ther. 2019;18(10):1787\u201399.","journal-title":"Mol Cancer Ther"},{"key":"7975_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pharmthera.2019.02.006","volume":"199","author":"SY Hwang","year":"2019","unstructured":"Hwang SY, Park S, Kwon Y. Recent therapeutic trends and promising targets in triple negative breast cancer. Pharmacol Ther. 2019;199:30\u201357.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"7975_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21(2):85\u2013100.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"7975_CR43","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.7150\/thno.50905","volume":"11","author":"M Zhao","year":"2021","unstructured":"Zhao M, Wang Y, Li L, Liu S, Wang C, Yuan Y, et al. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance. Theranostics. 2021;11(4):1845\u201363.","journal-title":"Theranostics"},{"key":"7975_CR44","doi-asserted-by":"crossref","unstructured":"Lee JY, Park JY, Kim DH, Kim HD, Ji YJ, Seo KH. Erigeron annuus protects PC12 neuronal cells from oxidative stress induced by ROS-mediated apoptosis. Evid Based Complement Alternat Med: eCAM. 2020;2020:3945194.","DOI":"10.1155\/2020\/3945194"},{"issue":"10","key":"7975_CR45","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.7150\/thno.56747","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Qi H, Liu Y, Duan C, Liu X, Xia T, et al. The double-edged roles of ROS in cancer prevention and therapy. Theranostics. 2021;11(10):4839\u201357.","journal-title":"Theranostics"},{"key":"7975_CR46","doi-asserted-by":"crossref","unstructured":"Wang H, Zhang C, Li M, Liu C, Wang J, Ou X, et al. Antimicrobial peptides mediate apoptosis by changing mitochondrial membrane permeability. Int J Mol Sci. 2022;23(21).","DOI":"10.3390\/ijms232112732"},{"issue":"1","key":"7975_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13046-019-1047-9","volume":"38","author":"Z Wang","year":"2019","unstructured":"Wang Z, Yin F, Xu J, Zhang T, Wang G, Mao M, et al. CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma. J experimental Clin cancer research: CR. 2019;38(1):44.","journal-title":"J experimental Clin cancer research: CR"},{"issue":"11","key":"7975_CR48","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1158\/0008-5472.CAN-13-2683","volume":"74","author":"GY Lee","year":"2014","unstructured":"Lee GY, Haverty PM, Li L, Kljavin NM, Bourgon R, Lee J, et al. Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes. Cancer Res. 2014;74(11):3114\u201326.","journal-title":"Cancer Res"},{"key":"7975_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.abb.2018.07.001","volume":"653","author":"A Tramonti","year":"2018","unstructured":"Tramonti A, Paiardini A, Paone A, Bouzidi A, Giardina G, Guiducci G, et al. Differential inhibitory effect of a pyrazolopyran compound on human serine hydroxymethyltransferase-amino acid complexes. Arch Biochem Biophys. 2018;653:71\u20139.","journal-title":"Arch Biochem Biophys"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07975-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:01:58Z","timestamp":1776672118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07975-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7975"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07975-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the clinical studies were conducted with relevant ethical regulations, including the Declaration of Helsinki and were approved by the Ethics Committee of the First Affiliated Hospital of Soochow University (Ethics code 2024662), and the informed consent was acquired from each patient. All animal experimental procedures were obtained official approval from the Laboratory Animal Center of Soochow University (approval no. 202308A0815 and 202405A0636).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"546"}}